These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35678260)

  • 1. Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor-associated myocarditis.
    Xu Y; Song Y; Liu X; Shi Y; Liu Y; Qian H; Gao X; Chen M; Pan R; Zhao J; Zhong W; Wu W; Wang M
    Cancer Commun (Lond); 2022 Sep; 42(9):902-905. PubMed ID: 35678260
    [No Abstract]   [Full Text] [Related]  

  • 2. The potential of auto-antigen-guided treatment of immune checkpoint inhibitor-mediated myocarditis.
    Zhu H; Huang YV; Wu SM
    Med; 2023 Jan; 4(1):13-14. PubMed ID: 36640753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New biomarker-based strategy screens for myocarditis after immune checkpoint inhibitor treatment.
    Nierengarten MB
    Cancer; 2023 May; 129(9):1304. PubMed ID: 37029508
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune Checkpoint Inhibitor-Induced Myocarditis With Concurrent Myasthenia Gravis.
    Kuniyoshi J; Huang R; Choi H; Bernas M; Techasatian W; Nishimura Y
    Can J Cardiol; 2023 Nov; 39(11):1646-1648. PubMed ID: 37330137
    [No Abstract]   [Full Text] [Related]  

  • 5. Sinus Node Dysfunction Co-occurring with Immune Checkpoint Inhibitor-associated Myocarditis.
    Nishikawa T; Kunimasa K; Ohta-Ogo K; Ikeda Y; Yasui T; Shioyama W; Oka T; Honma K; Hatakeyama K; Kumagai T; Fujita M
    Intern Med; 2022 Jul; 61(14):2161-2165. PubMed ID: 35283377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics, diagnosis and management of nivolumab-induced myocarditis: hypersensitivity myocarditis, or something else.
    Kounis NG; Mplani V
    Invest New Drugs; 2024 Aug; 42(4):478-479. PubMed ID: 39017983
    [No Abstract]   [Full Text] [Related]  

  • 7. Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.
    Valenti-Azcarate R; Esparragosa Vazquez I; Toledano Illan C; Idoate Gastearena MA; Gállego Pérez-Larraya J
    Neuromuscul Disord; 2020 Jan; 30(1):67-69. PubMed ID: 31839404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint inhibitor-related myositis and myocarditis with multiple myositis-specific/-associated antibodies.
    Isa M; Hongo Y; Sakamoto N; Yamazaki K; Takazaki H; Asakuma J; Ikewaki K; Suzuki K
    J Neurol Sci; 2023 Jan; 444():120528. PubMed ID: 36565689
    [No Abstract]   [Full Text] [Related]  

  • 9. A Diverse Range of Cardiac Adverse Events Associated with Immune Checkpoint Inhibitor Therapy.
    Murakata Y; Tajiri K
    Intern Med; 2022 Jul; 61(14):2099-2100. PubMed ID: 35283387
    [No Abstract]   [Full Text] [Related]  

  • 10. [Third degree atrio-ventricular blockade during a myocarditis occurring under anti-PD1 : Case report and literature review].
    Prevel R; Colin G; Calès V; Renault PA; Mazieres J
    Rev Med Interne; 2020 Apr; 41(4):284-288. PubMed ID: 31983550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal myocarditis associated with immune checkpoint inhibitor therapy.
    Hayashizaki M; Omote K; Tsuneta S; Nagai T; Anzai T
    Eur Heart J Cardiovasc Imaging; 2023 Nov; 24(12):e308. PubMed ID: 37694290
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case report of immune checkpoint inhibitor-induced myocarditis].
    Liao HL; Chen DD; Pan Y; Liu ZJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Jul; 50(7):710-712. PubMed ID: 35856230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report.
    Delombaerde D; Vervloet D; Berwouts D; Beckers R; Prenen H; Peeters M; Gremonprez F; Croes L; Vulsteke C
    J Med Case Rep; 2022 Jul; 16(1):275. PubMed ID: 35831829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study.
    Xie X; Wang L; Li Y; Xu Y; Wu J; Lin X; Lin W; Mai Q; Chen Z; Zhang J; Xie Z; Qin Y; Liu M; Lu M; Luo B; Zhou C
    Front Immunol; 2022; 13():879900. PubMed ID: 35924238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis.
    Zhang L; Zlotoff DA; Awadalla M; Mahmood SS; Nohria A; Hassan MZO; Thuny F; Zubiri L; Chen CL; Sullivan RJ; Alvi RM; Rokicki A; Murphy SP; Jones-O'Connor M; Heinzerling LM; Barac A; Forrestal BJ; Yang EH; Gupta D; Kirchberger MC; Shah SP; Rizvi MA; Sahni G; Mandawat A; Mahmoudi M; Ganatra S; Ederhy S; Zatarain-Nicolas E; Groarke JD; Tocchetti CG; Lyon AR; Thavendiranathan P; Cohen JV; Reynolds KL; Fradley MG; Neilan TG
    Circulation; 2020 Jun; 141(24):2031-2034. PubMed ID: 32539614
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment.
    Palaskas N; Lopez-Mattei J; Durand JB; Iliescu C; Deswal A
    J Am Heart Assoc; 2020 Jan; 9(2):e013757. PubMed ID: 31960755
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges and solutions in management of cardiotoxicity induced by checkpoint inhibitors.
    Mladosievičová B; Országhová Z; Jablonická M; Rečková M; Chovanec M; Mego M
    Klin Onkol; 2020; 33(5):350-355. PubMed ID: 33108879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why are immune adverse events so common with checkpoint inhibitor therapy?
    Lyubchenko T; Leung DYM; Goleva E
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):608-610. PubMed ID: 33774187
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac Monitoring.
    Katsume Y; Isawa T; Toi Y; Fukuda R; Kondo Y; Sugawara S; Ootomo T
    Intern Med; 2018 Nov; 57(21):3157-3162. PubMed ID: 29877257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer].
    Ying YC; Tang Q; Yang KW; Mi Y; Fan Y; Yu W; Song Y; He ZS; Zhou LQ; Li XS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):644-651. PubMed ID: 35950386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.